Author Information
Ross Stuart Berkowitz is affiliated with the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology at Brigham and Women's Hospital, Dana Farber Cancer Institute, and Harvard Medical School in Boston, MA, USA.Research Contributions
Ross Stuart Berkowitz has made significant contributions to the field of gynecologic oncology, with a particular focus on gestational trophoblastic disease, ovarian cancer, and cervical cancer. His recent works in 2022 include studies on methotrexate-resistant choriocarcinoma, decidual natural killer cells from term placenta and complete hydatidiform mole, and a systematic review on consolidation chemotherapy in postmolar low-risk gestational trophoblastic neoplasia. His research has provided valuable insights into the clinical characteristics and management of these diseases, as well as the predictors for single-agent resistance in gestational trophoblastic neoplasia.Aliases
Ross Stuart Berkowitz is also known by several aliases including Ross S. Berkowitz, R S Berkowitz, Rosss. Berkowitz, R. S. Berkowitz, R.s. Berkowitz, Ross S Berkowitz, Ross Berkowitz, and R Berkowitz.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
27106 |
| h-Index |
74 |
| Paper Count |
578 |
